http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0539372-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e493dbb326bdb84242fbc9af833f128e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D335-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D335-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-22 |
| filingDate | 1991-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1e8bf413e81db830edf6b3ce88e96bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9658e0293b02f14692d9775168cc76a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39de7b1866447145ff4a680927d2e9ed |
| publicationDate | 1993-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0539372-A1 |
| titleOfInvention | Therapeutic agents |
| abstract | Compounds of formula (I) in which X represents oxygen or sulfur; Z represents -CH = or -N = when X represents oxygen; Z represents -CH = when X represents sulfur; R5 represents hydrogen when R3 represents methyl, or R5 represents (a) when R3 represents a bond with either R2 sit R4; R6 represents hydrogen, halo, S (0) nY1, carboxy, carbamoyl, an acyl carboxylic group, an esterified carboxyl group or CONR12R13; R6 'represents hydrogen or methyl; or R6 and R6 'with the carbon atom to which they are linked represent cyclopropyl; R9 and R10 which may be similar or different, represent halo; or R9 represents hydrogen and R10 represents hydrogen, halo, trifluoromethyl, nitro, C1-6 alkyl, C1-6 alkoxy, hydroxy or an acyloxy carboxylic group; R12 represents methyl, ethyl or C3-8 cycloalkyl and R13 represents C1-6 alkyl optionally substituted by cyano, phenyl, a non-aromatic heterocyclic group of 3 to 8 elements, a heterocyclic aryl group of 5 or 6 elements or C3-8 cycloalkyl; or R13 represents phenyl optionally substituted by C2-6 alkoxycarbonyl or halo; or R12 and R13 with the nitrogen to which they are connected represent a non-aromatic heterocyclic group of 3 to 8 elements which can be substituted by an alkyl group (C1-6) acyloxy (C2-6); Y1 represents C1-6 alkyl; n is 0, 1 or 2 and R1, R2, R4, R7, R8 and R8 'are defined in the description. These compounds are used as immunomodulatory agents. |
| priorityDate | 1990-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1336.